Fermentation method

By conducting fermentation at a pH of 3.0-4.5, the method enhances aspartic protease production by reducing peptidase activity, resulting in a substantial yield increase of up to 200% compared to traditional methods.

WO2026234237A1PCT designated stage Publication Date: 2026-11-12NOVOZYMES AS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/EP2026/063418
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-06-04
Filing Date
2026-05-08
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing methods for producing aspartic proteases like chymosin through fermentation are inefficient, leading to low yields and high degradation due to the activity of host cell peptidases, which can be mitigated by maintaining a pH range of 3.0-4.5 during submerged fed-batch fermentation.

Method used

A fermentation method involving recombinant filamentous fungal host cells is conducted at a pH of 3.0-4.5, allowing for the secretion and autocatalytic maturation of aspartic proteases, such as chymosin, by reducing the activity of peptidases and enhancing expression.

Benefits of technology

This method significantly increases the yield of aspartic proteases, achieving up to 200% improvement in chymosin activity compared to traditional methods, while maintaining a stable and efficient production process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000013_0001_TABLE
    Figure IMGF000013_0001_TABLE
  • Figure IMGF000013_0002_TABLE
    Figure IMGF000013_0002_TABLE
  • Figure IMGF000013_0003_TABLE
    Figure IMGF000013_0003_TABLE
Patent Text Reader

Abstract

The invention provides an improved fermentation method for producing aspartic proteases, such as chymosin.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] FERMENTATION METHOD

[0002] Reference to a Sequence Listing

[0003] This application contains a Sequence Listing in computer readable form. The computer readable form is incorporated herein by reference.

[0004] FIELD OF THE INVENTION

[0005] The present invention relates to an improved fermentation method for producing an aspartic protease. In an embodiment, the aspartic protease is chymosin.

[0006] BACKGROUND

[0007] Aspartic protease, especially chymosin, is essential in the dairy industry for cheese production. Chymosin, or rennin, cleaves peptide bonds in casein, facilitating milk coagulation into curds for cheese. Its importance extends beyond cheese-making, showcasing biotechnology's role in enhancing food production. Traditionally sourced from calves, chymosin is now produced through fermentation, ensuring a reliable supply and promoting sustainability by reducing animal reliance. Additionally, chymosin aids in other dairy products and food processing where protein coagulation is needed, enhancing texture and flavor.

[0008] SUMMARY OF THE INVENTION

[0009] The present invention provides, in a first aspect, a method for producing an aspartic protease, comprising

[0010] (a) providing a fermentation medium comprising recombinant filamentous fungal host cells capable of secreting the aspartic protease or a proform thereof that can undergo autocatalytic maturation;

[0011] (b) subjecting the recombinant filamentous fungal host cells to submerged fed-batch fermentation at a pH in the range of pH 3.0-4.5, preferably a pH in the range of pH 3.5-4.5; and (c) optionally recovering the aspartic protease from the fermentation medium.

[0012] In a preferred embodiment, the aspartic protease is chymosin.

[0013] Other aspects and embodiments of the invention are apparent from the description and examples.

[0014] Unless otherwise indicated, or if it is apparent from the context that something else is meant, all percentages are percentage by weight (% w / w).

[0015] Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the specification and relevant art and should not be interpreted in anidealized or overly formal sense unless expressly so defined herein. For the sake of brevity and / or clarity, well-known functions or constructions may not be described in detail.

[0016] As used herein, the singular forms "a," "an," and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise.

[0017] Definitions

[0018] Sequence identity: The relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter “sequence identity”.

[0019] For purposes of the present invention, the sequence identity between two amino acid sequences is determined as the output of “longest identity” using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice etal., 2000, Trends Genet. 16: 276-277), preferably version 6.6.0 or later. The parameters used are a gap open penalty of 10, a gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. In order for the Needle program to report the longest identity, the -nobrief option must be specified in the command line. The output of Needle labeled “longest identity” is calculated as follows:

[0020] (Identical Residues x 100) / (Length of Alignment -Total Number of Gaps in Alignment)

[0021] Sequences

[0022] SEQ ID NO: 1: amino acid sequence of bovine chymosin proform;

[0023] SEQ ID NO: 2: amino acid sequence of mature bovine chymosin;

[0024] SEQ ID NO: 3: amino acid sequence of camel chymosin proform;

[0025] SEQ ID NO: 4: amino acid sequence of mature camel chymosin;

[0026] SEQ ID NO: 5: amino acid sequence of a variant of camel chymosin proform;

[0027] SEQ ID NO: 6: amino acid sequence of a variant of mature camel chymosin;

[0028] SEQ ID NO: 7: amino acid sequence of a fusion polypeptide comprising a signal peptide (amino acids 1-18), a “tractor” (amino acids 19-574), a chymosin propeptide (amino acids 575-616), and a mature camel chymosin (amino acids 617-939);

[0029] SEQ ID NO: 8: amino acid sequence of a fusion polypeptide comprising a “tractor” (amino acids 1-556), a chymosin propeptide (amino acids 557-598), and mature camel chymosin (amino acids 599-921)

[0030] SEQ ID NO: 9: amino acid sequence of hedgehog chymosin proform;

[0031] SEQ ID NO: 10: amino acid sequence of mature hedgehog chymosin;

[0032] SEQ ID NO: 11: amino acid sequence of a fusion polypeptide comprising a signal peptide (amino acids 1-18), a “tractor” (amino acids 19-640), a chymosin propeptide (amino acids 641-679), and a mature hedgehog chymosin (amino acids 680-1001).DETAILED DESCRIPTION

[0033] We have found that an improved fermentation yield of aspartic protease can be obtained by lowering the pH to below pH 4.5 in a submerged fed-batch fermentation of a recombinant filamentous fungal host cell. This low-pH fermentation may be preceded by fermentation at a pH above pH 4.5, for example, to quickly increase the amount of host cell biomass.

[0034] One possible explanation could be that host cell peptidases involved in degradation of aspartic proteases, such as chymosin, are inactive at low pH.

[0035] Many aspartic proteases, such as pepsin and chymosin, are expressed as an inactive zymogen precursor / proform that will be maturated (activated) at acidic pH by an autocatalytic mechanism. The present invention provides the advantage that not only is the expression of the aspartic protease proform significantly increased, but because of the low pH of the fermentation, the autocatalytic maturation will occur in situ during the fermentation.

[0036] Thus, the present invention provides a method for producing an aspartic protease, comprising

[0037] (a) providing a fermentation medium comprising recombinant filamentous fungal host cells capable of secreting the aspartic protease or a proform thereof that can undergo autocatalytic maturation;

[0038] (b) subjecting the recombinant filamentous fungal host cells to submerged fed-batch fermentation at a pH in the range of pH 3.0-4.5, preferably a pH in the range of pH 3.5-4.5; and (c) optionally recovering the aspartic protease from the fermentation medium.

[0039] In an embodiment, step (b) is preceded by fermentation at a pH in the range of pH 4.5-6. In an embodiment, the upper end of the pH range in step (b) is pH 4.4, pH 4.3, pH 4.2, pH 4.1, or pH 4.0.

[0040] In an embodiment, the lower end of the pH range in step (b) is pH 3.1, pH 3.2, pH 3.3, pH 3.4, or pH 3.5.

[0041] In an embodiment, the fermentation medium in step (c) comprises the aspartic protease in an amount of at least 0.1% w / w; preferably at least 0.5% w / w; more preferably at least 1% w / w.

[0042] In an embodiment, the fermentation medium in step (a) comprises at least 1% w / w of plant protein, preferably at least 2% or 3% w / w of plant protein. The plant protein may be selected from the group consisting of soybean protein, potato protein, corn protein, wheat protein, pea protein, rice bran protein, alfalfa protein, sunflower protein, cottonseed protein, and rapeseed protein.

[0043] In an embodiment, the aspartic protease is chymosin, such as bovine, goat, sheep, camel, alpaca, llama, or hedgehog chymosin, or a variant thereof having chymosin activity. The chymosin may have at least 60%, more than 70%, more than 80%, more than 90%, more than 95%, more than 96%, more than 97%, more than 98%, more than 99%, or 100% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.Aspartic protease

[0044] The aspartic protease (or alternatively aspartic endopeptidase) produced in the method of the invention is an enzyme identified by the Enzyme Commission Number 3.4.23.-. Aspartic proteases have two highly conserved aspartates in the active site and are optimally active at acidic pH.

[0045] A particularly preferred aspartic protease is chymosin.

[0046] Chymosin is identified by the Enzyme Commission Number 3.4.23.4, according to the classification system of enzymes established by the International Union of Biochemistry and Molecular Biology. It is also known as rennin. Chymosin cleaves the Phe105-Met106 bond of K-casein. The CAS No. for chymosin is 9001-98-3. Chymosin activity can be determined as described in the section of “Milk clotting assay for chymosin activity” of WO 2025 / 011942. Other methods include the method for determining the activity of chymosin in cleavage of milk K -kasein described by Siika-aho, M. (1983) Mikrobirenniinin tuottaminen, MSc Thesis.

[0047] Biotechnical Laboratory, VTT, Tietotie 2, 02150 Espoo, Finland.

[0048] Typically, recombinant chymosin is expressed as a proform consisting of the full-length mature polypeptide and a propeptide (prosequence). The chymosin proform can be maturated into active chymosin by proteolytic cleavage to remove the propeptide, resulting in the mature chymosin. Maturation of the chymosin proform can be autocatalytic.

[0049] A chymosin propeptide may be fused to a different polypeptide (a so-called tractor) that aids secretion from the host cell, as described in WO 2008 / 115596 or in EP application no. 25164089. In this situation, the fusion polypeptide consisting of the chymosin propeptide and the tractor is still considered a prosequence, and maturation into active chymosin still occurs by proteolytic cleavage, such as by autocatalytic cleavage, to remove the prosequence.

[0050] Examples of a tractor include Aspergillus niger amyloglucosidase (AnAMG) and Trametes cingulata amyloglucosidase (TcAMG).

[0051] Autocatalytic maturation means that one of the reaction products is also a catalyst for the maturation; thus, the mature chymosin can cleave the chymosin proform to release additional mature and active chymosin.

[0052] Non-limiting examples of chymosin include the bovine chymosin of SEQ ID NO: 1, and its mature form shown in SEQ ID NO: 2; the camel chymosin of SEQ ID NO: 3, and its mature form shown in SEQ ID NO: 4, as well as the hedgehog chymosin of SEQ ID NO: 9, and its mature form shown in SEQ ID NO: 10.

[0053] Other chymosins are known from sheep, goat, alpaca, llama, and hedgehog.

[0054] Also chymosin variants having improved milk-clotting properties are known and encompassed by the present invention. Examples of such variants are shown in SEQ ID NO: 5 (variant of camel chymosin proform) and SEQ ID NO: 6 (variant of mature camel chymosin).Host cell

[0055] The term "recombinant host cell", as used herein, means a host cell which harbors gene(s) encoding the aspartic protease and is capable of expressing said gene(s) to produce the aspartic protease. The aspartic protease coding gene(s) may be transformed, transfected, transduced, or the like, into the recombinant host cell using techniques well known in the art.

[0056] The recombinant host cell capable of producing the aspartic protease is of filamentous fungal origin. The choice of recombinant host cell will depend upon the gene coding for the aspartic protease and the source of said enzyme.

[0057] The filamentous fungal host cell may be a strain of a filamentous fungus selected from the group consisting of Acremonium, Agaricus, Alternaria, Aspergillus, Aureobasidium, Botryospaeria, Ceriporiopsis, Chaetomidium, Chrysosporium, Claviceps, Cochliobolus, Coprinopsis, Coptotermes, Corynascus, Cryphonectria, Cryptococcus, Diplodia, Exidia, Filibasidium, Fusarium, Gibberella, Holomastigotoides, Humicola, Irpex, Lentinula, Leptospaeria, Magnaporthe, Melanocarpus, Meripilus, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Piromyces, Poitrasia, Pseudoplectania, Pseudotrichonympha, Rhizomucor, Schizophyllum, Scytalidium, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trichoderma, Trichophaea, Verticillium, Volvariella, and Xylaria.

[0058] In an embodiment, the strain is an Acremonium cellulolyticus, Aspergillus aculeatus, Aspergillus awamori, Aspergillus foetidus, Aspergillus fumigatus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, Aspergillus oryzae, Chrysosporium inops, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium merdarium, Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium tropicum, Chrysosporium zonatum, Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichothecioides, Fusarium venenatum, Humicola grisea, Humicola insolens, Humicola lanuginosa, Irpex lacteus, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Penicillium funiculosum, Penicillium purpurogenum, Phanerochaete chrysosporium, Thielavia achromatica, Thielavia albomyces, Thielavia albopilosa, Thielavia australeinsis, Thielavia fimeti, Thielavia microspora, Thielavia ovispora, Thielavia peruviana, Thielavia setosa, Thielavia spededonium, Thielavia subthermophila, Thielavia terrestris, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, or Trichoderma viride strain.

[0059] In a more preferred embodiment, the filamentous fungal host cell is selected from the group consisting of Trichoderma and Aspergillus host cells, in particular a strain of Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei,Tnchoderma vmde\, Aspergillus awamon, Aspergillus fumigatus, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger or Aspergillus oryzae.

[0060] In a particular embodiment, the filamentous fungal host cell is a strain of Aspergillus niger, Aspergillus oryzae, or Trichoderma reesei.

[0061] Fermentation medium

[0062] The present invention may be useful for any fermentation in industrial scale, e.g., for any fermentation tank having culture media volume of at least 500 liters, preferably at least 5,000 liters, more preferably at least 50,000 liters.

[0063] The host cell producing the aspartic protease may be fermented in any fermentation medium known in the art. The fermentation medium may be a minimal medium as described in, e.g., WO 98 / 37179, or the fermentation medium may be a complex medium comprising complex nitrogen and carbon sources, wherein the complex nitrogen source may be partially hydrolyzed as described in WO 2004 / 003216.

[0064] The fermentation of the invention is a fed-batch fermentation process. In a fed-batch process, either none or part of the compounds comprising one or more nutrient(s) is added to the medium before the start of the fermentation and either all or the remaining part, respectively, of the compounds comprising one or more nutrients are fed during the fermentation process. The compounds which are selected for feeding can be fed together or separately to the fermentation process.

[0065] In one embodiment, the fermentation has a cultivation time of at least 24 hours, at least 48 hours, at least 72 hours, at least 96 hours, or at least 120 hours.

[0066] In a particular embodiment, the fermentation has at least 120 hours of cultivation time.

[0067] Plant proteins

[0068] The fermentation medium used in the method of the invention may comprise a plant protein. The plant protein may be any plant derived protein useful as a source of amino acids in a fermentation medium. Plant proteins are often isolated from whole-plant (meal) compositions, but some plants are so protein rich that they can be used almost directly as a plant protein source in a fermentation medium. Such whole-plant compositions may also serve as a source of other substrates, such as carbohydrates, lipids, and / or other metabolites.

[0069] Examples of plant proteins include, but are not limited to, soybean protein, potato protein, corn (gluten) protein, wheat (gluten) protein, pea protein, rice bran protein, alfalfa protein, sunflower protein, cottonseed protein, and rapeseed protein. A preferred plant protein is potato protein.Recovery

[0070] The aspartic protease produced in the method of the invention may be recovered from the fermentation medium using methods well-known in the art.

[0071] Such recovery processes may include a flocculation / precipitation step. In order to flocculate the fermentation medium a divalent salt may be added to the fermentation medium, in particular a calcium salt and / or a magnesium salt, e.g., calcium chloride or magnesium chloride. A preferred embodiment is a calcium salt, in particular calcium chloride.

[0072] The salt may be added to the fermentation medium in a concentration of 0.01-10% (w / w) per kg fermentation medium (un-diluted); preferably 0.5-10% (w / w) per kg fermentation medium (un-diluted); more preferably 1-9% (w / w) per kg fermentation medium (un-diluted); in particular 2-8% (w / w) per kg fermentation medium (un-diluted).

[0073] The flocculated cell debris may be removed by methods known in the art such as, but not limited to, filtration, e.g., drum filtration, membrane filtration, filter-press dead end filtration, cross-flow filtration, or centrifugation.

[0074] The resulting fermentation supernatant may then be further processed or refined by methods known in the art. For example, the protein may be recovered by conventional procedures including, but not limited to, further filtration such as ultra-filtration and dia-filtration, extraction, spray-drying, evaporation, precipitation or crystallization.

[0075] The terms "recover" or “recovery” means the removal of a polypeptide from at least one fermentation medium component selected from the list of a cell, a nucleic acid, or other specified material, e.g., recovery of the polypeptide from the whole fermentation medium, or from the cell-free fermentation medium, by polypeptide crystal harvest, by filtration, e.g. depth filtration (by use of filter aids or packed filter medias, cloth filtration in chamber filters, rotarydrum filtration, drum filtration, rotary vacuum-drum filters, candle filters, horizontal leaf filters or similar, using sheed or pad filtration in framed or modular setups) or membrane filtration (using sheet filtration, module filtration, candle filtration, microfiltration, ultrafiltration in either cross flow, dynamic cross flow or dead end operation), or by centrifugation (using decanter centrifuges, disc stack centrifuges, hydro cyclones or similar), or by precipitating the polypeptide and using relevant solid-liquid separation methods to harvest the polypeptide from the fermentation medium by use of classification separation by particle sizes. Recovery encompasses isolation and / or purification of the polypeptide.

[0076] The isolated protein may then be further purified and / or modified by a variety of procedures known in the art including, but not limited to, chromatography e.g. ion exchange, affinity, hydrophobic, chromatofocusing, and size exclusion and / or electrophoretic procedures e.g. preparative isoelectric focusing and / or differential solubility e.g., ammonium sulfate precipitation and / or extraction.

[0077] Microfiltration may involve a membrane having a size exclusion limit of more than 1000 kDa, more than 500 kDa, more than 100 kDa, or more than 50 kDa; and / or more than 5 pm,more than 1 pm, more than 0.5 pm, more than 0.4 pm, more than 0.3 pm, more than 0.2 pm, or more than 0.1 pm; or other filters with equivalent molecular weight exclusion properties; wherein the fermentation product is a filtrate of the microfiltration.

[0078] Subsequent to the microfiltration, or in a combined process, the fermentation product may be subjected to an ultra-filtration step, which involves a membrane having a size exclusion limit of more than 100 kDa, more than 80 kDa, more than 60 kDa, more than 50 kDa, more than 40 kDa, more than 30 kDa, more than 20 kDa, more than 15 kDa, more than 10 kDa, more than 5 kDa, or more than 1 kDa; or another filter with equivalent molecular weight exclusion properties.

[0079] The microbial fermentation product may be a liquid or solid formulation, or it may be used to prepare such formulations.

[0080] Liquid formulations may comprise polyols (polyhydric alcohols), for example in amounts of at least 10% w / w, at least 25% w / w, or at least 50% w / w. Polyols are alcohols with two or more hydroxyl groups. Useful polyols typically have a molecular weight lower than 500 g / mol.

[0081] Polyols include non-sugar polyols, such as glycerol, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, tripropylene glycol, polyethylene glycol (PEG), and sugar alcohols such as sorbitol, mannitol, erythritol, dulcitol, inositol, xylitol and adonitol. Polyols also include sugar polyols, such as mono- and disaccharides, like glucose, fructose, galactose, sucrose, lactose, maltose, and trehalose.

[0082] Solid formulations may be granulates prepared by for example high-shear granulation or fluid-bed granulation or combinations. Coatings with salt(s) or polymer(s) may also be applied.

[0083] Some further embodiments of the invention include:

[0084] Embodiment 1. A method for producing an aspartic protease, comprising

[0085] (a) providing a fermentation medium comprising recombinant filamentous fungal host cells capable of secreting the aspartic protease or a proform thereof that can undergo autocatalytic maturation;

[0086] (b) subjecting the recombinant filamentous fungal host cells to submerged fed-batch fermentation at a pH in the range of pH 3.0-4.5; and

[0087] (c) optionally recovering the aspartic protease from the fermentation medium.

[0088] Embodiment 2. The method of the preceding embodiment, wherein the fermentation in step (b) is carried out at a pH in the range of pH 3.5-4.5.

[0089] Embodiment 3. The method of the preceding embodiment, wherein the fermentation in step (b) is carried out at a pH in the range of pH 3.5-4.4.

[0090] Embodiment 4. The method of the preceding embodiment, wherein the fermentation in step (b) is carried out at a pH in the range of pH 3.5-4.3.

[0091] Embodiment 5. The method of the preceding embodiment, wherein the fermentation in step (b) is carried out at a pH in the range of pH 3.5-4.2.Embodiment 6. The method of the preceding embodiment, wherein the fermentation in step (b) is carried out at a pH in the range of pH 3.5-4.1.

[0092] Embodiment 7. The method of the preceding embodiment, wherein the fermentation in step (b) is carried out at a pH in the range of pH 3.5-4.0.

[0093] Embodiment 8. The method of any of the preceding embodiments, wherein step (b) is preceded by submerged fed-batch fermentation at a pH in the range of pH 4.5-6.

[0094] Embodiment 9. The method of any of the preceding embodiments, wherein the fermentation medium in step (c) comprises the aspartic protease in an amount of at least 0.1% w / w; preferably at least 0.5% w / w; more preferably at least 1% w / w.

[0095] Embodiment 10. The method of any of the preceding embodiments, wherein the fermentation medium in step (c) comprises the aspartic protease in an amount of at least 0.5% w / w.

[0096] Embodiment 11. The method of any of the preceding embodiments, wherein the fermentation medium in step (c) comprises the aspartic protease in an amount of at least 1% w / w.

[0097] Embodiment 12. The method of any of the preceding embodiments, wherein the fermentation medium in step (a) comprises at least 1% w / w of plant protein.

[0098] Embodiment 13. The method of any of the preceding embodiments, wherein the fermentation medium in step (a) comprises at least 2% w / w of plant protein.

[0099] Embodiment 14. The method of any of the preceding embodiments, wherein the fermentation medium in step (a) comprises at least 3% w / w of plant protein.

[0100] Embodiment 15. The method of any of embodiments 7-9, wherein the plant protein is selected from the group consisting of soybean protein, potato protein, corn protein, wheat protein, pea protein, rice bran protein, alfalfa protein, sunflower protein, cottonseed protein, and rapeseed protein.

[0101] Embodiment 16. The method of any of the preceding embodiments, wherein the aspartic protease is chymosin, such as bovine, goat, sheep, camel, alpaca, llama, or hedgehog chymosin, or a variant thereof having chymosin activity.

[0102] Embodiment 17. The method of embodiment 11 , wherein the chymosin has at least 60% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.

[0103] Embodiment 18. The method of embodiment 11, wherein the chymosin has at least 60% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.

[0104] Embodiment 19. The method of embodiment 11, wherein the chymosin has at least 60% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.

[0105] Embodiment 20. The method of embodiment 11, wherein the chymosin has at least 85% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.

[0106] Embodiment 21. The method of embodiment 11 , wherein the chymosin has at least 90% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.Embodiment 22. The method of embodiment 11, wherein the chymosin has at least 95% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.

[0107] Embodiment 23. The method of embodiment 11, wherein the chymosin has at least 96% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.

[0108] Embodiment 24. The method of embodiment 11, wherein the chymosin has at least 97% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.

[0109] Embodiment 25. The method of embodiment 11, wherein the chymosin has at least 98% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.

[0110] Embodiment 26. The method of embodiment 11, wherein the chymosin has at least 99% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO: 10.

[0111] Embodiment 27. The method of embodiment 11 , wherein the chymosin has 1, 2, 3, 4, or 5 substitutions, deletions, or insertions; preferably 1, 2, 3, 4, or 5 conservative substitutions as compared to the amino acid sequence shown as SEQ ID NO: 4 or SEQ ID NO: 10.

[0112] Embodiment 28. The method of embodiment 11 , wherein the chymosin comprises or consists of the amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 10.

[0113] Embodiment 29. The method of any of the preceding embodiments, wherein the filamentous fungal host cell is a strain selected from the group consisting of Trichoderma and Aspergillus host cells, such as a strain of Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, Trichoderma viride\, Aspergillus awamori, Aspergillus fumigatus, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, and Aspergillus oryzae.

[0114] Embodiment 30. The method of any of the preceding embodiments, wherein the filamentous fungal host cell is a strain of Aspergillus niger, Aspergillus oryzae, or Trichoderma reesei.

[0115] Embodiment 31. The method of any of the preceding embodiments, wherein the filamentous fungal host cell is a strain of Aspergillus niger.

[0116] Embodiment 32. The method of any of the preceding embodiments, wherein the fermentation medium is held in a fermentation tank having a volume of at least 500 liters.

[0117] Embodiment 33. The method of any of the preceding embodiments, wherein the fermentation medium is held in a fermentation tank having a volume of at least 5000 liters.

[0118] Embodiment 34. The method of any of the preceding embodiments, wherein the fermentation medium is held in a fermentation tank having a volume of at least 50000 liters.

[0119] Embodiment 35. The method of any of the preceding embodiments, wherein the fermentation has a cultivation time of at least 24 hours.

[0120] Embodiment 36. The method of any of the preceding embodiments, wherein the fermentation has a cultivation time of at least 48 hours.

[0121] Embodiment 37. The method of any of the preceding embodiments, wherein the fermentation has a cultivation time of at least 72 hours.Embodiment 38. The method of any of the preceding embodiments, wherein the fermentation has a cultivation time of at least 96 hours.

[0122] Embodiment 39. The method of any of the preceding embodiments, wherein the fermentation has a cultivation time of at least 120 hours.

[0123] Embodiment 40. The method of any of the preceding embodiments, wherein the aspartic protease is recovered from the fermentation medium.

[0124] Embodiment 41. The method of any of the preceding embodiments, wherein the recovery of the aspartic protease comprises subjecting the fermentation medium to a flocculation or precipitation to provide a fermentation medium supernatant.

[0125] Embodiment 42. The method of the preceding embodiment, wherein the recovery further comprises subjecting the fermentation medium supernatant to a membrane filtration.

[0126] Embodiment 43. The method of any of the preceding embodiments, wherein the recovery of the aspartic protease comprises a membrane filtration.

[0127] Embodiment 44. The method of the preceding embodiment, wherein the membrane filtration comprises a microfiltration.

[0128] Embodiment 45. The method of the preceding embodiment, wherein the microfiltration membrane has a size exclusion limit of 0.1 pm to 10 pm.

[0129] Embodiment 46. The method of the preceding embodiment, wherein the microfiltration membrane has a size exclusion limit of 0.5 pm to 5 pm.

[0130] Embodiment 47. The method of any of the preceding embodiments, wherein the recovery in step (c) comprises an ultra-filtration step.

[0131] Embodiment 48. The method of the preceding embodiment, wherein the ultra-filtration membrane has a size exclusion limit of less than 100 kDa.

[0132] Embodiment 49. The method of the preceding embodiment, wherein the ultra-filtration membrane has a size exclusion limit of less than 50 kDa.

[0133] Embodiment 50. The method of the preceding embodiment, wherein the ultra-filtration membrane has a size exclusion limit of less than 40 kDa.

[0134] Embodiment 51. The method of the preceding embodiment, wherein the ultra-filtration membrane has a size exclusion limit of less than 30 kDa.

[0135] Embodiment 52. The method of the preceding embodiment, wherein the ultra-filtration membrane has a size exclusion limit of less than 20 kDa.

[0136] Embodiment 53. The method of the preceding embodiment, wherein the ultra-filtration membrane has a size exclusion limit of less than 10 kDa.

[0137] EXAMPLES

[0138] Chemicals were commercial products of at least reagent grade.Chymosin activity measurement

[0139] Acid treatment

[0140] 10 pL of sample was mixed with 40 pL of drop buffer (500 mM Glycine-HCI Buffer Solution with 0.01% Triton, pH 2) in 96 well HDWP and incubated at 37°C for 1 hour. Then 450 pL of sample dilution buffer (500 mM NaOAc buffer, 1 mM CaCh, pH 5.5, 0.01% Triton) was added to the sample solution, mixed well and incubated at 30°C for at least 10 min.

[0141] IMCll plate assay

[0142] Acid treated sample was further diluted to appropriate activity range by sample dilution buffer (84 mM Acetate buffer, 1.5 mM Tween-80, pH 5.5). 20 pL of resulting sample was mixed with 200 pL of substrate (4% Low heat, low fat, spray dried milk powder, 7.5 mM CaCh) to start reaction. A dilution series of standardized chymosin rennet was included as reference standard. The mixture was incubated at 32°C for 1 hour while monitoring absorbance at 800 nm (A800) using microplate reader (Synergy2 or EPOCH, Biotek). A quadratic equation was generated from Vmax of dA800 / h and activity of the reference samples. Vmax of sample was fit to the equation to calculate chymosin activity.

[0143] EXAMPLE 1

[0144] Low pH expression of camel chymosin

[0145] Experimental procedure

[0146] An Aspergillus niger strain (AprfT phenotype) encoding the camel chymosin fusion polypeptide shown as SEQ ID NO: 7 was cultivated by fed-batch fermentation in a 5-liter stirred tank reactor.

[0147] Three fermentations were carried out using different pH profiles (see also Table 2):

[0148] A: constant at pH 4.75 (reference).

[0149] B: start at pH 4.75, ramp linearly down to pH 4.0, and continue at pH 4.0.

[0150] C: constant at pH 4.0.

[0151] Two independent experiments (“Trial 1” and “Trial 2”) were conducted, each including fermentations A-C, and the results are summarized in Table 2 below.

[0152] A seed fermentation was carried out and transferred to a main fermentation tank having a volume of 5L (ABLE, Japan) with an initial working weight of 3.0 kg. Prior to inoculation of the main tank, the growth medium was sterilized in situ for 30 minutes at 122°C.

[0153] The growth medium contained 3% w / w of soy protein. The pH was adjusted at 4.75 with 25% ammonia water before seed inoculation.Table 1. Main tank fermentation conditions

[0154] Initial pH 4.75 (see also Table 2)

[0155] Inoculation amount Approx. 10% w / v (240 g)

[0156] Temperature 34°C

[0157] Aeration 3.6 L / min

[0158] Feeding Started after 5 hours

[0159]

[0160] Table 2. pH set-points during fermentation.

[0161] Fermentation Time

[0162] 0 h - 96 h 96 h - 120 h 120 h - 190 h A (reference) pH 4.75 pH 4.75 pH 4.75

[0163] B pH 4.75 Linear ramp from pH 4.0 pH 4.75 to 4.0

[0164] C pH 4.0 pH 4.0 pH 4.0

[0165]

[0166] Results

[0167] The experimental data in Table 3 show a consistent improvement of lowering the pH of the fermentation.

[0168] Table 3. Chymosin activity in fermentation medium. by the end of the fermentation.

[0169] Fermentation pH Chymosin activity

[0170] Trial 1 Trial 2

[0171] A (reference) 4.75 = 100% = 100%

[0172] B 4.75 —> 4.0 200% 176% C 4.0 236% 193%

[0173]

[0174] EXAMPLE 2

[0175] Low pH expression of chymosin without soy protein

[0176] Experimental procedure

[0177] The experimental procedure of Example 1 was repeated using the same pH profiles, but where the growth medium contained no soy protein. The chymosin activity of fermentation A was about 60% of the chymosin activity achieved in Example 1.Results

[0178] Table 4. Chymosin activity in fermentation medium by the end of the fermentation.

[0179] Fermentation pH Chymosin activity

[0180] A (reference) 4.75 = 100%

[0181] B 4.75 —> 4.0 167% C 4.0 122%

[0182]

[0183] EXAMPLE 3

[0184] Expression of chymosin at pH 3 to pH 4

[0185] Experimental procedure

[0186] The experimental procedure of Example 1 was repeated, but this time using the following pH profiles:

[0187] A: constant at pH 4.0.

[0188] B: start at pH 4.0, ramp linearly down to pH 3.0, and continue at pH 3.0.

[0189] C: constant at pH 3.5.

[0190] Table 5. pH set-points during fermentation.

[0191] Fermentation Time

[0192] 0 h - 96 h 96 h - 120 h 120 h - 190 h A pH 4.0 pH 4.0 pH 4.0 B pH 4.0 Linear ramp from pH 3.0 pH 4.0 to 3.0

[0193] C pH 3.5 pH 3.5 pH 3.5

[0194]

[0195] Results

[0196] Table 6. Chymosin activity in fermentation medium by the end of the fermentation.

[0197] Fermentation pH Chymosin activity

[0198] A 4.0 = 100% B 4.0 3.0 96% C 3.5 103%

[0199]

[0200] EXAMPLE 4

[0201] Low pH expression of bovine chymosin

[0202] Experimental procedure

[0203] The experimental procedure of Example 1 was repeated, but the chymosin fusion polypeptide shown as SEQ ID NO: 7 was modified by replacing the camel chymosin proform of SEQ ID NO: 3 with the bovine chymosin proform of SEQ ID NO: 1. This results in expression of a bovine chymosin fusion polypeptide.

[0204] The following pH profiles were used instead of the pH profiles of Example 1 :

[0205] A: constant at pH 5.5.

[0206] B: constant at pH 4.75.

[0207] C: constant at pH 4.0.

[0208] Results

[0209] Table 7. Chymosin activity in fermentation medium by the end of the fermentation.

[0210] Fermentation pH Chymosin activity

[0211] A (reference) 5.5 33%

[0212] B (reference) 4.75 = 100%

[0213] C 4.0 154%

[0214]

[0215] EXAMPLE 5

[0216] Low pH expression of hedgehog chymosin

[0217] Experimental procedure

[0218] The experimental procedure of Example 1 was repeated, but the camel chymosin fusion polypeptide shown as SEQ ID NO: 7 was replaced by the hedgehog chymosin fusion polypeptide of SEQ ID NO: 11. This results in expression of a hedgehog chymosin fusion polypeptide.

[0219] The following pH profiles were used instead of the pH profiles of Example 1:

[0220] A: constant at pH 4.75.

[0221] B: constant at pH 4.0.Results

[0222] Table 8. Chymosin activity in fermentation medium by the end of the fermentation.

[0223] Fermentation pH Chymosin activity A (reference) 4.75 = 100% B 4.0 351%

[0224]

Claims

CLAIMS1. A method for producing an aspartic protease, comprising(a) providing a fermentation medium comprising recombinant filamentous fungal host cells capable of secreting the aspartic protease or a proform thereof that can undergo autocatalytic maturation;(b) subjecting the recombinant filamentous fungal host cells to submerged fed-batch fermentation at a pH in the range of pH 3.0-4.5, preferably a pH in the range of pH 3.5-4.5; and (c) optionally recovering the aspartic protease from the fermentation medium.

2. The method of the preceding claim, wherein the upper end of the pH range in step (b) is pH 4.4, pH 4.3, pH 4.2, pH 4.1, or pH 4.0.

3. The method of any of the preceding claims, wherein the lower end of the pH range in step (b) is pH 3.1, pH 3.2, pH 3.3, pH 3.4, or pH 3.5.

4. The method of any of the preceding claims, wherein step (b) is preceded by submerged fed-batch fermentation at a pH in the range of pH 4.5-6.

5. The method of any of the preceding claims, wherein the fermentation medium in step (c) comprises the aspartic protease in an amount of at least 0.1% w / w; preferably at least 0.5% w / w; more preferably at least 1% w / w.

6. The method of any of the preceding claims, wherein the fermentation medium in step (a) comprises at least 1% w / w of plant protein, preferably at least 2% or 3% w / w of plant protein.

7. The method of the preceding claim, wherein the plant protein is selected from the group consisting of soybean protein, potato protein, corn protein, wheat protein, pea protein, rice bran protein, alfalfa protein, sunflower protein, cottonseed protein, and rapeseed protein.

8. The method of any of the preceding claims, wherein the aspartic protease is chymosin, such as bovine, goat, sheep, camel, alpaca, llama, or hedgehog chymosin, or a variant thereof having chymosin activity.

9. The method of the preceding claim, wherein the chymosin has at least 60%, more than 70%, more than 80%, more than 90%, more than 95%, more than 96%, more than 97%, more than 98%, more than 99%, or 100% amino acid sequence identity to SEQ ID NO: 4 or SEQ ID NO:

10. The method of any of the preceding claims, wherein the filamentous fungal host cell is a strain selected from the group consisting of Trichoderma and Aspergillus host cells, such as a strain of Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei, Trichoderma viride\, Aspergillus awamori, Aspergillus fumigatus, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger, and Aspergillus oryzae preferably Aspergillus niger, Aspergillus oryzae, or Trichoderma reeser, more preferably Aspergillus niger.

11. The method of any of the preceding claims, wherein the fermentation medium is held in a fermentation tank having a volume of at least 500 liters; preferably at least 5,000 liters or 50,000 liters.

12. The method of any of the preceding claims, wherein the fermentation has a cultivation time of at least 24 hours; preferably at least 48 hours, at least 72 hours, at least 96 hours, or at least 120 hours.